APA (7th ed.) Citation

Issa, R., Calcagno, T., Motairek, I., Issa, R., Fahoury, A., & Majeed, Z. (2025). EVALUATING THE CARDIOVASCULAR BENEFITS OF SGLT2 INHIBITORS IN WOMEN WITH PERIPARTUM CARDIOMYOPATHY AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: A PROPENSITY-MATCHED ANALYSIS. Journal of the American College of Cardiology (JACC), 85(12), 2661. https://doi.org/10.1016/S0735-1097(25)03145-6

Chicago Style (17th ed.) Citation

Issa, Rochell, Tess Calcagno, Issam Motairek, Ryan Issa, Alan Fahoury, and Zoha Majeed. "EVALUATING THE CARDIOVASCULAR BENEFITS OF SGLT2 INHIBITORS IN WOMEN WITH PERIPARTUM CARDIOMYOPATHY AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: A PROPENSITY-MATCHED ANALYSIS." Journal of the American College of Cardiology (JACC) 85, no. 12 (2025): 2661. https://doi.org/10.1016/S0735-1097(25)03145-6.

MLA (9th ed.) Citation

Issa, Rochell, et al. "EVALUATING THE CARDIOVASCULAR BENEFITS OF SGLT2 INHIBITORS IN WOMEN WITH PERIPARTUM CARDIOMYOPATHY AND HEART FAILURE WITH PRESERVED EJECTION FRACTION: A PROPENSITY-MATCHED ANALYSIS." Journal of the American College of Cardiology (JACC), vol. 85, no. 12, 2025, p. 2661, https://doi.org/10.1016/S0735-1097(25)03145-6.